Stifel Financial Corp Decreases Position in Teleflex Incorporated (NYSE:TFX)

Stifel Financial Corp trimmed its position in Teleflex Incorporated (NYSE:TFX - Free Report) by 71.3% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 3,557 shares of the medical technology company's stock after selling 8,858 shares during the period. Stifel Financial Corp's holdings in Teleflex were worth $880,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also bought and sold shares of the company. Janus Henderson Group PLC increased its holdings in shares of Teleflex by 2.8% during the third quarter. Janus Henderson Group PLC now owns 5,376,452 shares of the medical technology company's stock valued at $1,329,704,000 after acquiring an additional 147,147 shares in the last quarter. Cooke & Bieler LP increased its stake in Teleflex by 23.3% during the 2nd quarter. Cooke & Bieler LP now owns 912,797 shares of the medical technology company's stock valued at $191,989,000 after purchasing an additional 172,335 shares in the last quarter. TD Asset Management Inc raised its holdings in shares of Teleflex by 12.0% in the second quarter. TD Asset Management Inc now owns 456,081 shares of the medical technology company's stock worth $95,928,000 after buying an additional 48,832 shares during the last quarter. Massachusetts Financial Services Co. MA lifted its stake in shares of Teleflex by 0.4% during the third quarter. Massachusetts Financial Services Co. MA now owns 427,579 shares of the medical technology company's stock worth $105,749,000 after buying an additional 1,884 shares during the period. Finally, Bank of New York Mellon Corp grew its holdings in shares of Teleflex by 6.6% during the second quarter. Bank of New York Mellon Corp now owns 425,647 shares of the medical technology company's stock valued at $89,526,000 after buying an additional 26,325 shares during the last quarter. 95.62% of the stock is owned by hedge funds and other institutional investors.

Teleflex Trading Down 0.6 %

NYSE:TFX traded down $0.99 during trading hours on Wednesday, hitting $177.26. The company had a trading volume of 114,964 shares, compared to its average volume of 388,592. Teleflex Incorporated has a 1 year low of $171.69 and a 1 year high of $256.85. The company has a market cap of $8.23 billion, a P/E ratio of 35.24, a P/E/G ratio of 1.84 and a beta of 1.16. The company has a 50-day moving average of $200.10 and a 200 day moving average of $218.94. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37.

Teleflex (NYSE:TFX - Get Free Report) last posted its quarterly earnings results on Thursday, October 31st. The medical technology company reported $3.49 earnings per share for the quarter, beating the consensus estimate of $3.38 by $0.11. The business had revenue of $764.40 million during the quarter, compared to analysts' expectations of $768.68 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The business's revenue for the quarter was up 2.4% on a year-over-year basis. During the same quarter in the prior year, the company posted $3.64 EPS. Sell-side analysts expect that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Monday, December 16th. Shareholders of record on Friday, November 15th were paid a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a yield of 0.77%. The ex-dividend date was Friday, November 15th. Teleflex's dividend payout ratio (DPR) is presently 27.04%.

Analysts Set New Price Targets

TFX has been the subject of several recent research reports. Mizuho reduced their target price on shares of Teleflex from $275.00 to $250.00 and set a "neutral" rating for the company in a report on Friday, November 1st. Royal Bank of Canada lowered their target price on Teleflex from $275.00 to $245.00 and set an "outperform" rating on the stock in a research note on Friday, November 1st. Needham & Company LLC reiterated a "hold" rating on shares of Teleflex in a research report on Monday, December 16th. StockNews.com raised Teleflex from a "hold" rating to a "buy" rating in a report on Thursday, November 28th. Finally, Truist Financial dropped their price objective on shares of Teleflex from $227.00 to $200.00 and set a "hold" rating on the stock in a research note on Wednesday, December 18th. Three equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $252.50.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.